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Visceral leishmaniasis (VL), caused by Leishmania donovani, is a systemic infection
of reticulo-endothelial system. There is currently no protective vaccine against VL and
chemotherapy is increasingly limited due to appearance of drug resistance to first line
drugs such as antimonials and amphotericin B. In the present study, by using a murine
model of leishmaniasis we evaluated the function played by soluble leishmanial antigen
(SLA)-pulsed CpG-ODN-stimulated dendritic cells (SLA–CpG–DCs) in restricting the intra-
cellular parasitic growth. We establish that a single dose of SLA–CpG–DC vaccination is
sufficient in rendering complete protection against L. donovani infection. In probing the
possible mechanism, we observe that SLA–CpG–DCs vaccination results in the significant
decrease in Foxp3+GITR+CTLA4+CD4+CD25+ regulatory T cells (Treg) cell population in
Leishmania-infected mice.Vaccination with these antigen-stimulated dendritic cells results
in the decrease in the secretion of TGF-β by these Treg cells by possible regulation of the
SMAD signaling. Moreover, we demonstrate that a CXC chemokine, IFN-γ-inducible protein
10 (IP-10; CXCL10), has a direct role in the regulation of CD4+CD25+ Treg cells in SLA–
CpG–DC-vaccinated parasitized mice as Treg cells isolated from IP-10-depleted vaccinated
mice showed significantly increased TGF-β production and suppressive activity.
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INTRODUCTION
Visceral leishmaniasis (VL), a neglected tropical disease is caused
by Leishmania donovani, a protozoan parasite (1, 2). Leishma-
nia promastigotes infect the cells of the reticulo-endothelial
system where they multiply (2). Emergence of severe drug
resistance against the first line drugs prompts new therapeutic
approach (3, 4).
We have previously reported that mice vaccinated with a single
dose of soluble leishmanial antigen (SLA)-pulsed DC stimulated
with CpG oligodeoxynucleotides or CpG-ODN (SLA–CpG–DCs)
were protected against a subsequent leishmanial challenge (5).
Stimulation with CpG-ODN, a TLR9 ligand along with SLA acti-
vates the dendritic cells and results in the development of Leishma-
nia antigen-specific cytotoxic T lymphocytes, which destroys the
parasite in vivo (5). CpG–ODN also causes the DCs to produce
CXCL10, a CXC chemokine, which has previously reported anti-
leishmanial properties (6). Besides dendritic cells, the major pro-
ducers of CXCL10 are monocytes and macrophages (7). Moreover,
a strong induction of CXCL10 is observed in Leishmania resis-
tant B6 mice, thus linking it with a strong pro-inflammatory Th1
immune response (8). Earlier from our lab, we have also demon-
strated that exogenously administered CXCL10 besides regulating
the intracellular parasitic load can also regulate the CD4+CD25+
regulatory T cells (Treg) cells in Leishmania-infected mice (9). In
the present study, we have investigated the potential role of SLA–
CpG–DCs vaccination in the regulation of immunosuppressive
CD4+CD25+ Treg cells in Leishmania-infected mice.
Regulatory T cells are a subpopulation of T cells, which sup-
press immune responses of other cell types (10). Characteristic
markers of Tregs are CD25 (10), glucocorticoid-induced tumor
necrosis factor receptor (GITR) (11), cytotoxic T lymphocyte anti-
gen 4 (CTLA4) (12) and Foxp3 (13). Tregs have been reported to
play a fundamental role in the progression of leishmanial disease
predominantly by suppressing Th1 immune responses (14, 15).
Tregs secrete high levels of immunosuppressive Th2 cytokines
such as IL-10 and TGF-β (10). IL-10, a classical Th2 cytokine
is produced by many different cells such as CD4+ T cells, Tregs,
macrophages, dendritic cells, and even NK cells (16). However,
the major source of IL-10 during human VL is CD4+CD25−
T cells but not CD4+CD25+ Treg cells (17). CD4+CD25+ Tregs
on the other hand are the major producers of TGF-β during active
VL (18). TGF-β, a regulatory cytokine has several down regula-
tory effects on the host immune system; it inhibits TNF-α and
IFN-γ production from activated T cells (19), decreases the nitric
oxide production (20) and also abrogates the antigen presenting
function of host macrophages (21). Treatment with neutralizing
antibodies to TGF-β to susceptible mice results in resistance to
Leishmania infection (22). Besides, TGF-β is also important for
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the in vivo expansion of CD4+CD25+ Treg cells (23). Tregs iso-
lated from TGF-β-deficient mice are defective in their suppressive
property (24). Effective TGF-β signaling in Tregs also requires
phosphorylation and subsequent nuclear translocation of SMAD
proteins specifically SMAD4 (25–27).
Our results show that SLA–CpG–DCs vaccination inhibits the
generation of CD4+CD25+ Treg cells in Leishmania-infected mice
along with the TGF-β production by these Tregs by possible reg-
ulation of SMAD signaling. In addition, we demonstrate that
the SLA–CpG–DCs-mediated reduction of Tregs can be entirely
attributable to CXC chemokine IP-10, as significant increase in
CD4+CD25+ Treg cells is observed in SLA–CpG–DCs-vaccinated
parasitized mice depleted of IP-10.
MATERIALS AND METHODS
ETHICS STATEMENT
This study was carried out in strict accordance with the recom-
mendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All experimental
animal protocols received prior approval from the Institutional
Animal Ethical Committee (Bose Institute, Registration Number:
95/99/CPCSEA).
ANIMALS, PARASITES, AND REAGENTS
BALB/c mice were purchased from the National Center for
Laboratory Animal Sciences, India. For each experiment, 8–10
mice (4–6 weeks old) were used, regardless of sex. L. dono-
vani strain AG-83 (MHOM/IN/1983/AG-83) was maintained
in vitro in Medium 199 (Sigma) containing 10% fetal calf
serum (FCS; Gibco BRL). Experiments were performed with
stationary phase promastigotes. The CpG-ODN 1826 (5′-
TCCATGACGTTCCTGACGTT-3′) and the control-ODN (non-
CpG-ODN, 5’-TCCATGAGCTTCCTGAGCTT-3’) was obtained
from InvivoGen. CXCL10-depleting antibody was obtained from
R&D Systems.
PREPARATION OF DENDRITIC CELLS
Bone marrow-derived DCs from BALB/c mice were generated
as described previously (28). Non-adherent cells were collected,
and 1× 106 cells were placed in plates containing 1 ml of com-
plete medium with GM-CSF (150 U/ml; R&D Systems) and IL-4
(75 U/ml; R&D Systems) as originally described earlier (5). Half
of the medium was replaced on day 3, 5, and 7 and fresh medium
containing GM-CSF and IL-4 was added. On day 8 of culture, most
cells had acquired typical dendritic morphology. These cells were
used as the source of DCs in subsequent experiments.
DC VACCINATION
For DC-based vaccination, DCs were pulsed with both SLA and
CpG-ODNs (29) as originally described earlier (5). In case of dual
stimulation, CpG-ODN (10µg/ml) or control-ODN (10µg/ml)
was added to the media for last 6 h after 12 h of SLA stimula-
tion. DCs were then washed with PBS thrice and injected i.v. (106
cells in 100µl of PBS/mouse) into mice through the tail vein.
One week later, mice were infected intravenously with 1× 107 sta-
tionary phase L. donovani promastigotes. Mice were sacrificed on
day 56 post-infections. Spleen and liver parasitic loads were deter-
mined from Giemsa-stained impression smears, calculated as the
number of parasites per 1000 nucleated cells× organ weight (in
milligrams) and expressed in Leishman Donovan Units (LDU)
(30). After 28 days of infection, spleens from infected BALB/c
mice were removed aseptically, and a single-cell suspension was
prepared. Briefly, spleen homogenate was subjected to centrifu-
gation on a Histopaque-1077 (Sigma) gradient and splenocytes
were collected, washed, and resuspended in RPMI-1640 complete
medium supplemented with 10% FCS.
IN VIVO DEPLETION OF CXCL10
For in vivo depletion of CXCL10, anti-mouse CXCL10 mAb (R&D
Systems) were injected intraperitoneal (i.p.) on day 0 (250 mg), day
2 (100 mg), and day 4 (100 mg) after SLA–CpG–DCs vaccination
as originally described earlier (5). These mice were subsequently
infected with 1× 107 stationary phase L. donovani promastigotes
after 7 days of initial vaccination. Two hundred fifty milligrams of
anti-CXCL10 mAb was again injected i.p on days 10, 15, and 24 of
initial vaccination. Depletion efficiencies were assessed at regular
intervals.
PURIFICATION OF CD4+ T CELLS
CD4+ T cells were purified from splenocytes from differently
treated mice by positive selection using magnetic beads as orig-
inally described earlier (9). CD4+ T cells were purified by anti-
mouse CD4 (L3T4)-magnetic particles (BD Biosciences). To fur-
ther separate CD4+ T cells into CD25+ and CD25− populations,
total CD4+ T cells were isolated by negative selection using mag-
netic beads followed by positive selection using anti-CD25 mag-
netic beads on a magnetic separator column into CD4+CD25+
and CD4+CD25− populations as per manufacturer’s suggested
protocol (MagCellect Treg isolation kit, R&D Systems). The cells
were stained with anti-CD25 mAb, and the purity of cell prepara-
tions was determined by using FACS analysis (FACSCalibur; BD
Labware). The purities of CD4+CD25+ and CD4+CD25− T cells
were routinely >90 and 99%, respectively.
Additional analyses of T cell phenotypes were also performed
using FACS where splenocytes were stained using 1µg Ab/1× 106
cells and either run immediately or fixed (3% paraformaldehyde
in PBS). In some cases, the splenocytes were first stained with
CD4 FITC followed by permeabilization using FACS permeabiliz-
ing solution (BD Pharmingen) and FOXP3-PE staining. The panel
of Abs used for T cell phenotyping included the following: CD4,
CD25, GITR, Foxp3, and CTLA4 (BD Biosciences). The dot plots
were derived from the gated events based on the region encircling
lymphocytes, which was set using a forward versus side scatter dis-
play, and all fluorescent parameters were gated on this population
and analyzed on a Flow cytometer (FACSCalibur), using the Cell
Quest program on at least 10,000 events.
PROLIFERATION ASSAY AND CYTOKINE ELISA
Splenic responder CD4+CD25− T cells (5× 105) and T-depleted,
mitomycin C-treated syngeneic APCs (5× 105) were cultured
in the absence or presence of increasing numbers of splenic
CD4+CD25+ Treg cells for 4 days in 96-well, round-bottom
plates as originally described earlier (9). Soluble leishmanial anti-
gen (SLA) (10µg/ml) was added to the culture for stimula-
tion. One microcurie of [3H] thymidine was added 18 h before
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harvesting, and incorporated radioactivity was determined on
a beta emission reader. Supernatants were collected from the
co-culture of responder CD4+CD25− and CD4+CD25+ Treg
cells (1:1) at 24 h (for IL-2) or 72 h (for other cytokines). In
some cases, splenocytes (2× 106 cells/ml per well), CD4+CD25−
T cells (1× 106 cells/ml per well), or CD4+CD25+ Treg cells
(1× 106 cells/ml per well) from different sets of treatment were
stimulated with SLA (10µg/ml) for 24 h (IL-2) or 72 h (for other
cytokines). The levels of cytokines in supernatants were deter-
mined by specific ELISAs using paired mAbs for IL-2, IL-10, IFN-γ,
and TGF-β along with the appropriate mouse cytokine controls
(BD Biosciences and R&D Systems).
FLOW CYTOMETRY
For intracellular cytokine analysis, flow cytometry was performed
for the determination of IFN-γ, IL-12, TGF-β, and IL-10 pro-
duced by CD4+ T cells in differently treated mice at the single-cell
level as originally described earlier (9). In another experiment,
CD4+CD25+ Treg cells were analyzed for Foxp3-positive Treg cells
producing TGF-β. Splenocytes or MACS-purified CD4+CD25+
Treg cells from different groups of experimental mice were stim-
ulated for 20–24 h with SLA (10µg/ml). Brefeldin A (10µg/ml)
was added to the cultures 2 h before harvesting. The cells were
washed in PBS containing 0.1% NaN3/1% FCS at 4°C, and some
sets were stained with FITC-conjugated anti-CD4. Cells were then
permeabilized by treatment with FACS permeabilizing solution
(BD Pharmingen) and stained with PE-conjugated IFN-γ, FITC-
conjugated IL-12, FITC or PE-conjugated anti-mouse TGF-βmAb,
PE-conjugated anti-mouse IL-10 mAb, PE-conjugated Foxp3 anti-
hamster mAb, or isotype-matched control mAb and analyzed on a
Flow cytometer (FACSCalibur) using the Cell Quest program on
at least 10,000 events.
REAL-TIME PCR QUANTIFICATION
Total RNA was extracted from 2× 106 CD4+CD25+ T cells
or CD4+CD25− T cells with use of TRI Reagent (Sigma),
according to the manufacturer’s protocol as originally described
previously (9). Isolated RNA (1µg) was then reverse tran-
scribed using Revert Aid M-MuLV Reverse Transcriptase (Fer-
mentas). The resulting complementary DNA was used for real-
time (RT) PCR to detect different Treg cell-specific markers with
use of the ABI 7500 RT-PCR system with the DNA-binding
SYBR green dye (Applied Biosystems). Glyceraldehyde-3 phos-
phate dehydrogenase (GAPDH) was used as a reference. The
forward- and reverse-specific primer sequences used were as fol-
lows: CTLA4 Forward, 5′-GGACGCAGATTTATGTCATTGATC-
3′, CTLA4 Reverse, 5′-CCAAGCTAACTGCGAC AAGGA-3′;
Foxp3 Forward, 5′-CGTACACCCAGGAAAGACAG-3′, Foxp3
Reverse, 5′-ATCCAGGAGATGATCTGCTTG-3′; GITR Forward,
5′-GACGGTCACTGCAGACTTTG-3′; GITR Reverse, 5′-GCCAT
GACCAGGAAGATGAC-3′. The reaction conditions involved an
initial activation step (5 min at 95°C) and a cycling step (denat-
uration for 30 s at 94°C, annealing for 30 s at 58.5°C, and exten-
sion for 1 min at 72°C for 40 cycles), followed by melting curve
analysis. Detection of dequenched probe, calculation of threshold
cycles, and further analysis of these data were performed using
the Sequence Detector software (Applied Biosystems). Relative
changes in CTLA4, Foxp3, and GITR messenger RNA (mRNA)
expression were compared with unstimulated control, normalized
to GAPDH, and quantified by the 2−ddCt method.
PREPARATION OF CELL LYSATE AND IMMUNOBLOT ANALYSIS
Cell lysates were prepared as described earlier (31). Equal amounts
of protein (30µg) in each lane were subjected to SDS-10% poly-
acrylamide gel electrophoresis and transferred to a nitrocellulose
membrane. The membrane was blocked overnight with 3% BSA
in Tris–saline buffer (pH7.5), and immunoblotting was carried
out for detecting phosphorylated or dephosphorylated forms of
SMAD4 as described previously (32).
STATISTICAL ANALYSIS
A minimum of five mice were used per group for in vivo experi-
ments. The data, represented as mean± standard deviation (SD),
is from one experiment, which was performed at least three times.
Student’s t -test was employed to assess the significance of the dif-
ferences between the mean values of control and experimental
groups. A P value of 0.05 was considered significant and <0.001
was considered highly significant.
RESULTS
SLA–CpG–DC VACCINATION MEDIATES EFFECTIVE PROTECTION
AGAINST VISCERAL LEISHMANIASIS THROUGH A POTENT
PRO-INFLAMMATORY RESPONSE
Our results demonstrated that SLA-pulsed DCs in the presence of
TLR9 agonist, CpG-ODN (SLA–CpG–DCs), acquired the ability
to induce complete protection against L. donovani. SLA–CpG–
DCs-vaccinated BALB/c mice on day 56 of infection, showed
marked decrease in parasitic burden; 96± 2.6 and 97± 1.9%
reduction in hepatic and splenic parasite burden, respectively,
compared with PBS-treated infected controls (Figure 1A). Mice
vaccinated with SLA and control-ODN-stimulated dendritic cells
(SLA-Cont. ODN–DCs) were unable to give any protection against
the leishmanial challenge (Figure 1A). Moreover, the protection
conferred by SLA–CpG–DC vaccination against L. donovani infec-
tion is significantly dependent on a Th1 polarized anti-parasitic
immune response (Figures 1B,C). Splenocytes from differently
vaccinated mice at 28 days post-treatment were re-stimulated with
SLA to evaluate the percentages of T cells secreting various pro-
inflammatory or anti-inflammatory cytokines. There was about
sixfold increase in IFN-γ secreting CD4+ T cells along with
nearly fivefold increase in IL-12 secreting CD4+ T cells in spleno-
cytes from SLA–CpG–DC-vaccinated parasitized mice compared
with only infected mice (Figures 1B,C). Moreover, there was
nearly fourfold decrease in TGF-β secreting CD4+ T cells along
with nearly threefold decrease in IL-10-secreting CD4+ T cells
in splenocytes from SLA–CpG–DC-vaccinated parasitized mice
compared with only infected mice (Figures 1D,E).
SLA–CpG–DCs VACCINATION LEADS TO DECREASE IN SPLENIC
CD25+CTLA4+GITR+Foxp3+CD4+ T CELLS IN L. DONOVANI -INFECTED
MICE
To check whether SLA–CpG–DCs vaccination of L. donovani-
infected mice can modulate the Treg cells, which have been pre-
viously reported to play a crucial role in disease progression (33),
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FIGURE 1 | Soluble leishmanial antigen–CpG–DC vaccination mediates
effective protection against visceral leishmaniasis through a potent
pro-inflammatory response. (A) Mice were vaccinated with SLA and
CpG-ODN-pulsed DCs, SLA and control-ODN-pulsed DCs, or phosphate
buffered saline (PBS; control) followed by intravenous infection with 1×107
stationary phase Leishmania donovani promastigotes after 7 days. Mice were
sacrificed on day 56 after infection. Levels of parasite burden in liver and
spleen samples were determined by stamp–smear method and expressed in
Leishman Donovan Units (LDU). Results are from three independent
experiments and represent the mean values± standard errors of the means
for five animals per group per time point. **P <0.001, compared to
PBS-treated infected mice. In another set of experiments, splenocytes
(2×106) from control, L. donovani -infected (28 days), and
SLA–CpG–DC-vaccinated infected mice (28 days) were assessed for
intracellular (B) IFN-γ, (C) IL-12, (D) IL-10, or (E) TGF-β staining, which was
performed as mentioned in Section “Materials and Methods” and analyzed
by flow cytometry. Magnetically purified CD4+ T cells were analyzed for
IL-12-PE, IFN-γ-PE, IL-10-PE, or TGF-β-PE staining to detect CD4+IL-12+, CD4+
IFN-γ+, CD4+IL-10+, or CD4+ TGF-β+ T cells. The bar graphs represent the
mean dot plot values based on the region encircling positive cells from three
independent experiments *P <0.05, compared with infected sets. The error
bars represent mean±SD of three mice per group.
FACS analysis was performed to evaluate the frequency and phe-
notype of splenic Treg cell population. We observed a significant
decrease from 23% to 11% in CD4+CD25+Foxp3+ Treg cells
in splenocytes isolated from SLA–CpG–DCs-vaccinated infected
mice compared to only infected mice (Figures 2A,B). Other Treg
cell-specific markers like CTLA4 and GITR showed a significant
decrease in splenocytes isolated from SLA–CpG–DC-vaccinated
infected mice compared to infected sets (Figures 2C,D). We
observed 2.5-fold decrease in GITR and threefold decrease in
CTLA4 mRNA levels in SLA–CpG–DC-vaccinated infected sets
in comparison with only infected sets.
SLA–CpG–DC VACCINATION REDUCES THE SUPPRESSIVE PROPERTIES
OF THE CD4+CD25+Foxp3+ T CELLS IN L. DONOVANI -INFECTED MICE
To study whether the Treg cells isolated from the Leishmania-
infected BALB/c mice can suppress the function of effector T cells,
we performed co-culture experiments using CD4+CD25+ and
CD4+CD25− T cells purified from spleen of differently treated
mice. We observed that CD4+CD25+ Treg cells isolated from
untreated infected mice can efficiently suppress the proliferation
of responder CD4+CD25− T cells in a dose-dependent manner.
Whereas, CD4+CD25+ Treg cells, isolated from SLA–CpG–DC-
vaccinated infected mice, could not suppress the proliferation of
responder CD4+CD25− T cells (Figure 3A).
Moreover, CD4+CD25+ Treg cells from SLA–CpG–DC-
vaccinated mice failed to suppress the release of IL-2 when co-
cultured with CD4+CD25− responder T cells (1:1) compared to
CD4+CD25+ Treg cells isolated from infected mice (Figure 3B).
Additionally, CD4+CD25+ Treg cells from infected mice signifi-
cantly abrogated the IFN-γ secretion by responder CD4+CD25−
T cells, while CD4+CD25+ Treg cells from SLA–CpG–DC-
vaccinated parasitized mice, could not suppress the IFN-γ pro-
duction from responder CD4+CD25− T cells demonstrating
parasite-specific T cell responses (Figure 3C).
SLA–CpG–DC VACCINATION LEADS TO REDUCED TGF-β SECRETION
FROM T REGULATORY CELLS IN L. DONOVANI -INFECTED MICE
SLA–CpG–DC vaccination of L. donovani-infected mice results in
a significant decrease in Th2 cytokine secreting CD4+ T cells, i.e.,
IL-10 and TGF-β (Figures 4B,C). As expected, FoxP3 levels were
higher in CD4+CD25+ Treg cells isolated from infected group
of mice. On the contrary, CD4+CD25− T cells showed lower
expression of Foxp3 mRNA during infection (Figure 4A). Now
to delineate which of these two cells are the major producer of
IL-10 and TGF-β, we evaluated the anti-inflammatory cytokines
secreted by CD4+CD25+ Treg cells and CD4+CD25− T cells
from different groups of mice. CD4+CD25− and CD4+CD25+
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FIGURE 2 | Effect of SLA–CpG–DCs vaccination on the frequency and
phenotype ofT regulatory cells. (A) CD4+ T cells (1×106) were purified
from infected and indicated treatment groups of mice 28 days after
infection, plated aseptically followed by fixation and staining for T regulatory
cell-specific markers like FITC-conjugated CD25 and PE-conjugated FoxP3
mentioned in Section “Materials and Methods.” The data was analyzed by
flow cytometry in each group of untreated and differently treated BALB/c
mice have been presented. Data represent the mean±SD for three
animals per group. In a separate experiment, CD4+CD25+ Treg cells
(2×106) were purified from spleen of differently treated mice by MACS as
described in Section “Materials and Methods.” These magnetically purified
Treg cells were collected in TRIZOL for mRNA extraction and real-time PCR
to study mRNA expression of T regulatory cell markers. Quantitative
RT-PCR showing the expression of Foxp3 (B), GITR (C), and CTLA4 mRNA
(D), where the data were presented as changes (n-fold) from uninfected
control cells. *P <0.05 and **P <0.001, compared with T regulatory cells
isolated from infected mice. The data represent the mean±SD of data
from three independent experiments, which yielded similar results.
T cells from control mice showed lower levels of IL-10 and TGF-β
(Figures 4B,C).
In infected mice, CD4+CD25− T cells are the major produc-
ers of IL-10. On the other hand, CD4+CD25+ Treg cells are the
major source of TGF-β release. Interestingly, significant decrease
in TGF-β release from CD4+CD25+ Treg cells was observed in
CD4+CD25+ Treg cells isolated from SLA–CpG–DC-vaccinated
infected sets compared with infected mice, while CD4+CD25− T
cells showed a significant reduction in IL-10 release in vaccinated
group of mice compared with infected sets (Figures 4B,C).
In another experiment, CD4+CD25+ Treg cells, isolated from
different groups of animals, were analyzed for TGF-β secret-
ing Foxp3+ Treg cells. We observed higher levels (69.24%)
of TGF-β-secreting Foxp3+ Treg cells in infected mice, which
were significantly abridged (24.56%) in SLA–CpG–DC-vaccinated
infected mice (Figure 4D), indicating decrease of TGF-β secretion
FIGURE 3 | Soluble leishmanial antigen–CpG–DCs vaccination reduces
the suppressive properties of the CD4+CD25+Foxp3+ T cells in
L. donovani -infected mice. (A) CD4+CD25+ T regulatory cells and
CD4+CD25− T cells were purified from spleen of differently treated mice
(Materials and Methods) after 4 weeks post-infection. CD4+CD25− T cells
(5×105) and T-depleted, mitomycin C-treated syngeneic APCs (5×105)
were stimulated with SLA (10µg/ml) and co-cultured in the presence of
splenic CD4+CD25+ T cells(1:1 ratio) from differently treated sets for 4 days.
Proliferation was determined by an 18 h (3H) thymidine incorporation assay.
Data are presented as counts per minute (CPM)×103. The supernatants
were collected at 24 h for IL-2 (B) or at 72 h for IFN-γ (C) following
stimulation with SLA (10µg/ml) and levels of cytokines were determined by
ELISA. The error bars represent mean±SD of triplicate cultures. The
experiments were performed three times, of which one set of
representative data is shown (**P < 0.001 and *P <0.05).
from CD4+CD25+Foxp3+ Treg cells following SLA–CpG–DC
vaccination during VL.
IP-10 DEPLETION ABROGATES THE TGF-β SIGNALING IN CD4+CD25+
Treg CELLS IN SLA–CpG–DC-VACCINATED PARASITIZED MICE
We have previously demonstrated that the induction of anti-
leishmanial protective immunity by SLA–CpG–DCs is entirely
dependent on IP-10 (5). Moreover, our lab has also shown that
exogenously administered IP-10 can decrease the TGF-β secre-
tion in Leishmania-infected mice (9). So to examine possible
involvement of IP-10 in the secretion of TGF-β from CD4+CD25+
Treg cells following SLA–CpG–DCs vaccination, we vaccinated the
mice, infected it with Leishmania and monitored the course of
infection in the presence or absence of IP-10 (Figure 5A).
CD4+CD25+ Treg cells from IP-10 depleted SLA–CpG–DC-
vaccinated mice produced significantly higher amount of TGF-β
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FIGURE 4 | Effect of SLA–CpG–DC vaccination on IL-10 andTGF-β
release fromT regulatory cells. (A) CD4+CD25+ Treg cells or CD4+CD25−
T cells (2×105), purified from spleen of differently treated mice (see
Materials and Methods) 4 weeks post-infection, were collected in TRIZOL
for mRNA extraction and real-time PCR to study Foxp3 mRNA expression
or were stimulated with SLA for 72 h, after which the cell supernatants
were collected for estimation of IL-10 (B) and TGF-β (C) by ELISA. All data
were presented as mean±SD of three triplicate wells. One of the three
independent experiments is shown. *P <0.001 indicates statistically
significant differences compared with infected sets. In a separate
experiment, CD4+CD25+ T regulatory cells (1×106), isolated from spleen
of differently treated mice (4 weeks post-infection), were assessed for
TGF-β and Foxp3 (D), which was performed as mentioned in Section
“Materials and Methods,” and analyzed by Flow cytometry. Magnetically
purified CD4+CD25+ cells were analyzed for FoxP3-PE staining to detect
FoxP3+CD4+CD25+ cells (P1 gated cell population in the sorting scheme).
These FoxP3+CD4+CD25+ cells were further analyzed for TGF-β-FITC
staining to detect TGF-β+ FoxP3+CD4+CD25+T cells (P2 gated cell
population in the sorting scheme). The bar graphs represent the mean dot
plot values based on the region encircling positive cells from three
independent experiments. **P <0.001 and *P <0.05, compared with T
regulatory cells isolated from infected mice. The data represent the
mean±SD of data from three independent experiments, which yielded
similar results.
together with fourfold increase in their suppressive property
compared with IP-10 non-depleted vaccinated parasitized mice,
which showed significant reduction in TGF-β secretion along with
clear decrease in the suppressive property of the CD4+CD25+
Treg cells (Figures 5B,C). These findings clearly demonstrate the
involvement of IP-10 in the regulation of CD4+CD25+ Treg cell
functioning in SLA–CpG–DC-vaccinated parasitized mice.
Efficient TGF-β signaling requires proper activation of SMAD4
(27). To establish whether SMAD4 is involved in the SLA–CpG–
DC-mediated regulation of TGF-β signaling in CD4+CD25+ Treg
cells, we studied the phosphorylation of SMAD4 in CD4+CD25+
Treg cells during SLA–CpG–DC vaccination. Increased levels of
phospho-SMAD4 was observed in CD4+CD25+ Treg cells iso-
lated from infected mice, however CD4+CD25+ Treg cells iso-
lated from SLA–CpG–DC-vaccinated mice showed lower levels of
phospho-SMAD4 indicating SLA–CpG–DC-mediated regulation
of TGF-β signaling through SMAD4 modulation (Figure 5D).
Though, increased levels of phospho-SMAD4 in CD4+CD25+
Treg cells in IP-10-depleted vaccinated parasitized mice suggest the
involvement of IP-10 in the SLA–CpG–DCs-mediated suppression
of TGF-β.
DISCUSSION
Our results describe a novel strategy using a DC-based vaccina-
tion to confer significant protection against Leishmania pathogen.
SLA–CpG–DC vaccination of L. donovani-infected mice showed
significant protection as marked reduction in the hepatic and
splenic parasitic burden is observed (Figure 1A). Besides this, sig-
nificantly higher numbers of IL-12 and IFN-γ secreting T cells are
observed in SLA–CpG–DC-vaccinated parasitized mice compared
to unvaccinated parasitized mice. At the same time lower numbers
of TGF-β and IL-10-producing CD4+ T cells in vaccinated mice
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FIGURE 5 | IFN-γ-inducible protein 10 depletion abrogates theTGF-β
signaling in CD4+CD25+ Treg cells in SLA–CpG–DC-vaccinated parasitized
mice. (A) Assessment of depletion efficiency. Levels of IP-10 were measured
at indicated days from IP-10 depleted and non-depleted
SLA–CpG–DC-vaccinated parasitized mice. Splenic cells were isolated at
indicated time points and levels of IP-10 were measured by sandwich ELISA.
The experiments were carried out twice. (B) CD4+CD25+ Treg cells (1× 106)
purified from spleen of indicated groups of L. donovani -infected (28 days)
mice were stimulated with SLA for 72 h. Level of TGF-β in cell culture
supernatants of indicated treatment groups was determined by ELISA.
Asterisks indicate statistically significant induction (*P <0.05, **P <0.001) of
TGF-β production compared with infected sets. (C) CD4+CD25+ T regulatory
cells and CD4+CD25− T cells were purified from spleen of differently treated
mice (see Materials and Methods) after 28 days post-infection. CD4+CD25− T
cells (5×105) and T-depleted, mitomycin C-treated syngeneic APCs (5× 105)
were stimulated with SLA (10µg/ml) in the presence of splenic CD4+CD25+ T
cells (1:1) for 4 days. Proliferation was determined by an 18-h (3H) thymidine
incorporation assay. Data were presented as cpm×103. **P <0.001
compared with infected sets. (D) In a separate experiment, CD4+CD25+ Treg
cells (2×106), purified from spleen of indicated groups of mice, were
stimulated with SLA for 30 and 60 min. The cells were lysed and subjected to
Western blotting with anti-pSMAD4 and anti-SMAD4 as described in Section
“Materials and Methods”. The experiments were carried out three times, of
which one set of representative data is shown.
indicate efficient suppression of Th2 cytokines (Figures 1B–E).
Besides CD4+ T cells, SLA–CpG–DC vaccination also reduces the
number of CD25+Foxp3+CD4+ T regulatory cells in the para-
sitized mice along with their immunosuppressive molecules GITR
and CTLA4 (Figures 2A–D).
Recently it has been shown that CD4+CD25− T cells derived,
but not CD4+CD25+ derived IL-10 plays a major role in the
murine model of VL (34, 35). Our results also indicate that
SLA–CpG–DC vaccination abrogates the secretion of IL-10 from
CD4+CD25− T cells, which can be crucial for the parasite clear-
ance (Figure 4B). CD4+CD25+ Treg cells from infected mice, on
the other hand secrete higher amounts of TGF-β (Figure 4C).
TGF-β, while inhibiting pro-inflammatory cytokine responses
aids in the multiplication of the parasite inside the host (36).
Additionally, TGF-β is also critical for the effective functioning
of Treg cells and has been implicated to play a critical role in
the persistence of Leishmania infection. Vaccination with SLA–
CpG–DC inhibits TGF-β production from CD4+CD25+Foxp3+
Treg cells (Figure 4D) and also reduces their suppressive activ-
ity (Figure 3A), which is critical for the resistance against
Leishmania (37).
Besides, TGF-β plays a decisive role in the generation and
expansion of Treg cells and also in the induction of FoxP3
and CTLA4 in Treg cells (27, 38). SMAD proteins play a criti-
cal role here for the efficient TGF-β signaling (27). Our results
indicate that SLA–CpG–DC vaccination restricted the parasite-
induced enhanced phosphorylation of SMAD4 (Figure 5D)
and thus can efficiently regulate the TGF-β signaling in Treg
cells. The use of neutralizing IP-10 antibody during SLA–CpG–
DC vaccination provided evidence that IP-10 besides regulating
TGF-β signaling, also regulates the suppressive activity of these
Treg cells (Figures 5B,C). Our previous finding revealed that
SLA–CpG–DCs vaccination results in significant enhancement of
IFN-γ secreting CD8+ cytotoxic T lymphocytes along with signif-
icant increase in granzyme and perforin secreting CD8+ T cells,
which most likely contributes to the protection (5). The evidence
www.frontiersin.org June 2014 | Volume 5 | Article 261 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Majumder et al. DC vaccination regulates Treg functioning
presented here indicates that the protection was also dependent
on the reduction of CD4+CD25+Foxp3+ Treg cells. Collectively,
these findings illustrate that SLA–CpG–DCs vaccination induces
a strong Th1 response by effective modulation of Treg cell func-
tioning and activation of cytotoxic CD8+ T cells, representing
an antigen-specific immune response against Leishmania-induced
pathogenesis.
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